Article Text

Download PDFPDF
212 Information needs and research in diabetic macular edema
  1. Vanesa Ramos-García1,2,3,
  2. Marta Alonso-Plasencia4,
  3. Rodrigo Abreu-González4,
  4. Alberto Afonso-Rodríguez4,
  5. Amado Rivero-Santana1,2,3,
  6. María Magdalena Alberto-Pestano4,
  7. María Padilla-Ruíz2,5,
  8. Saturnino Gismero-Moreno3,5,6,
  9. Yolanda Álvarez-Pérez1,2,3,
  10. Andrea Duarte-Díaz1,2,3,
  11. Anthea Santos-Álvarez1,
  12. Himar González-Pacheco1,2,3,
  13. Lilisbeth Perestelo-Pérez1,2,3,6
  1. 1Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain
  2. 2The Spanish Network of Agencies for Health Technology Assessment and Services of the National Health System (RedETS), Tenerife, Spain
  3. 3Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Tenerife, Spain
  4. 4Ophthalmology Department, University Hospital of Nuestra Señora de Candelaria, Santa Cruzde Tenerife, Spain
  5. 5Ophthalmology Department, University Hospital Costa del Sol, Marbella, Spain
  6. 6PhD student in Biomedicine, Translational Research, and New Health Technologies, Universityof Málaga Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain


Introduction The main objective is to design and evaluate the acceptability and effectiveness of a Patient Decision Aid (PtDA) for Shared Decision Making (SDM) in patients with Diabetic Macular Edema (DME). In the initial phase, we will explore the information and research needs related to the DME itself and the available treatments, which both patients and health care professionals identify in this area, through a Delphi study.

Methods In total, participants were involved in three Delphi rounds. During the initial round, individuals responded to a maximum of three questionnaires. Within these questionnaires, they were prompted to: 1) identify up to five questions pertaining to DME and/or its treatments for which they desired or would have desired more information, or questions they believed were inadequately researched; 2) explore, from their perspective, five questions they considered insufficiently addressed; and 3) provide insights into the decision-making needs associated with selection a treatment for DME.

Results Since September 2023, 39 participants (26 ophthalmology professionals and 15 patients with DME) have been enrolled and the first Delphi round has been completed. Preliminary results from all three Delphi rounds will be presented at the congress.

Discussion and Conclusion Identifying unmet information and research needs, especially those relevant to patients with DME and/or ophthalmology professionals, in the context of treatment, taking into account the health status and individual circumstances of each patient, has the potential to improve the clinical relationship and facilitate an SDM process. Additionally, it will lead to the creation of PtDA tailored to individual values and personal needs.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.